Deciphera Pharmaceuticals, Inc. (DCPH) Social Stream



Deciphera Pharmaceuticals, Inc. (DCPH): $15.73

0.55 (+3.62%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add DCPH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#43 of 365

in industry

DECIPHERA PHARMACEUTICALS INC (DCPH) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering DECIPHERA PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 10 $64 $10 $23.8 $14.9 59.73%
2021-11-30 10 $64 $10 $19.1 $14.9 28.19%
2021-12-01 10 $64 $10 $18.1 $14.9 21.48%
2022-02-09 10 $64 $10 $17.4 $14.9 16.78%
2022-02-10 10 $64 $8 $17.2 $14.9 15.44%
2022-02-28 10 $64 $6 $16.7 $14.9 12.08%
2022-04-26 10 $64 $6 $16.8 $14.9 12.75%
2022-05-09 10 $64 $6 $16.6 $14.9 11.41%
2022-07-27 9 $64 $6 $18.125 $14.9 21.64%
2022-08-02 9 $64 $6 $17.222 $14.9 15.58%
2022-08-05 9 $23 $6 $14.666 $14.9 -1.57%
2022-08-11 9 $23 $6 $14.777 $14.9 -0.83%
2022-08-30 10 $25 $6 $15.8 $14.9 6.04%
2022-09-12 10 $25 $6 $17.2 $14.9 15.44%
2022-11-03 10 $25 $6 $17.9 $14.9 20.13%
2022-11-04 10 $25 $6 $18.65 $14.9 25.17%
2023-01-03 9 $25 $6 $19.388 $14.9 30.12%
2023-01-04 10 $28 $9 $20.6 $14.9 38.26%
2023-01-18 10 $28 $9 $21.1 $14.9 41.61%
2023-01-26 10 $30 $9 $21.6 $14.9 44.97%
2023-02-08 10 $30 $9 $21.5 $14.9 44.3%
2023-04-25 9 $30 $9 $21.5 $14.9 44.3%
2023-05-04 9 $30 $9 $21.2 $14.9 42.28%
2023-07-26 8 $30 $9 $21.333 $14.9 43.17%
2023-10-31 8 $30 $9 $22 $14.9 47.65%
2023-11-01 8 $34 $9 $23.777 $14.9 59.58%
2023-11-20 10 $34 $9 $22.8 $14.9 53.02%
2023-12-15 10 $34 $9 $23.4 $14.9 57.05%

The Trend in the Analyst Price Target


DCPH's average price target has moved up $6 over the prior 22 months.

DCPH reports an average of 58.84% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-18 10 28 9 21.100 20.61 2.38%
2023-01-26 10 30 9 21.600 17.98 20.13%
2023-04-24 9 30 9 21.500 14.32 50.14%
2023-05-04 8 30 9 21.333 13.28 60.64%
2023-10-31 8 30 9 22.000 11.99 83.49%

DCPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 8 0 1 1 1 10

The Trend in the Broker Recommendations


DCPH's average broker recommendation rating improved by 0.73 over the prior 16 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • DECIPHERA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2954.13% of all US stocks.
  • In terms of how DECIPHERA PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 796.63% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, DECIPHERA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 890.11% of them.
  • In terms of how DECIPHERA PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 2247.11% of that group.

Stocks similar to DECIPHERA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZYME, AUPH, and HCM.

Is DCPH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!